miRNA-214 is related to invasiveness of human non-small cell lung cancer and directly regulates alpha protein kinase 2 expression

Genes Chromosomes and Cancer

Volumn 52, Issue 10, 2013, Pages 895-911

  Salim, Hogir ^a   Arvanitis, Alexandros ^a   de Petris, Luigi ^a   Kanter, Lena ^a   Hååg, Petra ^a   Zovko, Ana ^a   Özata, Deniz Mahmut ^a   Lui, Weng Onn ^a   Lundholm, Lovisa ^a   Zhivotovsky, Boris ^a   Lewensohn, Rolf ^a   Viktorsson, Kristina ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA PROTEIN KINASE 2; ANTAGOMIR; ARGONAUTE 2 PROTEIN; CYCLIN DEPENDENT KINASE 6; MESSENGER RNA; MICRORNA 214; PREGNANCY ASSOCIATED PLASMA PROTEIN A; PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INDUCED PROTEIN 3; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER STAGING; CELL MEMBRANE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENETIC REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; IN VITRO STUDY; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; MALE; METASTASIS POTENTIAL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; TUMOR CELL;

BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE 6; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE KNOCKDOWN TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PROTEIN KINASES; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84883052379     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.22085     Document Type: Article

References (44)

1. Aydogdu E, Katchy A, Tsouko E, Lin CY, Haldosen LA, Helguero L, Williams C. 2012. MicroRNA-regulated gene networks during mammary cell differentiation are associated with breast cancer. Carcinogenesis 33:1502-1511.
2. Barbie DA, Tamayo P, Boehm JS, Kim SY, Moody SE, Dunn IF, Schinzel AC, Sandy P, Meylan E, Scholl C, et al. 2009. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 462:108-112.
3. Bergh J, Nilsson K, Ekman R, Giovanella B. 1985. Establishment and characterization of cell lines from human small cell and large cell carcinomas of the lung. Acta Pathol Microbiol Immunol Scand A 93:133-147.
4. Blasco RB, Francoz S, Santamaria D, Canamero M, Dubus P, Charron J, Baccarini M, Barbacid M. 2011. c-Raf, but not B-Raf, is essential for development of K-Ras oncogene-driven non-small cell lung carcinoma. Cancer Cell 19:652-663.
5. Boldt HB, Conover CA. 2011. Overexpression of pregnancy-associated plasma protein-A in ovarian cancer cells promotes tumor growth in vivo. Endocrinology 152:1470-1478.
6. Bulut I, Coskun A, Ciftci A, Cetinkaya E, Altiay G, Caglar T, Gulcan E. 2009. Relationship between pregnancy-associated plasma protein-A and lung cancer. Am J Med Sci 337:241-244.
7. Carretero J, Shimamura T, Rikova K, Jackson AL, Wilkerson MD, Borgman CL, Buttarazzi MS, Sanofsky BA, McNamara KL, Brandstetter KA, et al. 2010. Integrative genomic and proteomic analyses identify targets for LKB1-deficient metastatic lung tumors. Cancer Cell 17:547-559.
8. Cherni I, Weiss GJ. 2011. miRNAs in lung cancer: Large roles for small players. Future Oncol 7:1045-1055.
9. Coleman MH, Bueno R. 2011. Role of adjuvant chemotherapy in NSCLC (stages I to III). Surg Oncol Clin N Am 20:757-767.
10. De petris LKL, Melotti F, Bergman P, Kölbeck K-G, Hellborg H, Adolfsson J, Lewensohn R, Lehtiö J. 2011. Clinical implications of the tumor expression of S100 proteins in NSCLC. J Thorac Oncol 6:S965-S966.
11. Derfoul A, Juan AH, Difilippantonio MJ, Palanisamy N, Ried T, Sartorelli V. 2011. Decreased microRNA-214 levels in breast cancer cells coincides with increased cell proliferation, invasion and accumulation of the Polycomb Ezh2 methyltransferase. Carcinogenesis 32:1607-1614.
12. Fuller ES, Smith MM, Little CB, Melrose J. 2012. Zonal differences in meniscus matrix turnover and cytokine response. Osteoarthritis Cartilage 20:49-59.
13. Guibourdenche J, Frendo JL, Pidoux G, Bertin G, Luton D, Muller F, Porquet D, Evain-Brion D. 2003. Expression of pregnancy-associated plasma protein-A (PAPP-A) during human villous trophoblast differentiation in vitro. Placenta 24:532-539.
14. Hynes NE, Lane HA. 2005. ERBB receptors and cancer: The complexity of targeted inhibitors. Nat Rev Cancer 5:341-354.
15. Ikeda K, Satoh M, Pauley KM, Fritzler MJ, Reeves WH, Chan EK. 2006. Detection of the argonaute protein Ago2 and microRNAs in the RNA induced silencing complex (RISC) using a monoclonal antibody. J Immunol Methods 317:38-44.
16. Ji H, Ramsey MR, Hayes DN, Fan C, McNamara K, Kozlowski P, Torrice C, Wu MC, Shimamura T, Perera SA, et al. 2007. LKB1 modulates lung cancer differentiation and metastasis. Nature 448:807-810.
17. Kalluri R, Weinberg RA. 2009. The basics of epithelial-mesenchymal transition. J Clin Invest 119:1420-1428.
18. Kang DW, Park MH, Lee YJ, Kim HS, Lindsley CW, Alex Brown H, Min do S. 2011. Autoregulation of phospholipase D activity is coupled to selective induction of phospholipase D1 expression to promote invasion of breast cancer cells. Int J Cancer 128:805-816.
19. Karginov FV, Conaco C, Xuan Z, Schmidt BH, Parker JS, Mandel G, Hannon GJ. 2007. A biochemical approach to identifying microRNA targets. Proc Natl Acad Sci USA 104:19291-19296.
20. Kim WY, Perera S, Zhou B, Carretero J, Yeh JJ, Heathcote SA, Jackson AL, Nikolinakos P, Ospina B, Naumov G, et al. 2009. HIF2alpha cooperates with RAS to promote lung tumorigenesis in mice. J Clin Invest 119:2160-2170.
21. Kuhajda FP, Eggleston JC. 1985. Pregnancy-associated plasma protein A. A clinically significant predictor of early recurrence in stage I breast carcinoma is independent of estrogen receptor status. Am J Pathol 121:342-348.
22. Lawrence JB, Oxvig C, Overgaard MT, Sottrup-Jensen L, Gleich GJ, Hays LG, Yates JR, 3rd, Conover CA. 1999. The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci USA 96:3149-3153.
23. Lee YB, Bantounas I, Lee DY, Phylactou L, Caldwell MA, Uney JB. 2009. Twist-1 regulates the miR-199a/214 cluster during development. Nucleic Acids Res 37:123-128.
24. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. 2003. Prediction of mammalian microRNA targets. Cell 115:787-798.
25. Limame R, Wouters A, Pauwels B, Fransen E, Peeters M, Lardon F, De Wever O, Pauwels P. 2012. Comparative analysis of dynamic cell viability, migration and invasion assessments by novel real-time technology and classic endpoint assays. PLoS One 7e46536.
26. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408.
27. Nguyen DX, Chiang AC, Zhang XH, Kim JY, Kris MG, Ladanyi M, Gerald WL, Massague J. 2009. WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis. Cell 138:51-62.
28. Pan H, Hanada S, Zhao J, Mao L, Ma MZ. 2012. Protein secretion is required for pregnancy-associated plasma protein-a to promote lung cancer growth in vivo. PLoS One 7:e48799.
29. Papadopoulos GL, Reczko M, Simossis VA, Sethupathy P, Hatzigeorgiou AG. 2009. The database of experimentally supported targets: A functional update of TarBase. Nucleic Acids Res 37(Database issue):D155-D158.
30. Peng RQ, Wan HY, Li HF, Liu M, Li X, Tang H. 2012. MicroRNA-214 suppresses growth and invasiveness of cervical cancer cells by targeting UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7. J Biol Chem 287:14301-14309.
31. Penna E, Orso F, Cimino D, Tenaglia E, Lembo A, Quaglino E, Poliseno L, Haimovic A, Osella-Abate S, De Pitta C, et al. 2011. microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C. EMBO J 30:1990-2007.
32. Puyol M, Martin A, Dubus P, Mulero F, Pizcueta P, Khan G, Guerra C, Santamaria D, Barbacid M. 2010. A synthetic lethal interaction between K-Ras oncogenes and Cdk4 unveils a therapeutic strategy for non-small cell lung carcinoma. Cancer Cell 18:63-73.
33. Qiang R, Wang F, Shi LY, Liu M, Chen S, Wan HY, Li YX, Li X, Gao SY, Sun BC, et al. 2011. Plexin-B1 is a target of miR-214 in cervical cancer and promotes the growth and invasion of HeLa cells. Int J Biochem Cell Biol 43:632-641.
34. Radisky ES, Radisky DC. 2010. Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer. J Mammary Gland Biol Neoplasia 15:201-212.
35. Rio DC, Ares M, Jr., Hannon GJ, Nilsen TW. 2010. Purification of RNA using TRIzol (TRI reagent). Cold Spring Harb Protoc 2010:pdb prot5439.
36. Salim H, Akbar NS, Zong D, Vaculova AH, Lewensohn R, Moshfegh A, Viktorsson K, Zhivotovsky B. 2012. miRNA-214 modulates radiotherapy response of non-small cell lung cancer cells through regulation of p38MAPK, apoptosis and senescence. Br J Cancer.
37. Schliekelman MJ, Gibbons DL, Faca VM, Creighton CJ, Rizvi ZH, Zhang Q, Wong CH, Wang H, Ungewiss C, Ahn YH, et al. 2011. Targets of the tumor suppressor miR-200 in regulation of the epithelial-mesenchymal transition in cancer. Cancer Res 71:7670-7682.
38. Shedden K, Taylor JM, Enkemann SA, Tsao MS, Yeatman TJ, Gerald WL, Eschrich S, Jurisica I, Giordano TJ, Misek DE, et al. 2008. Gene expression-based survival prediction in lung adenocarcinoma: A multi-site, blinded validation study. Nat Med 14:822-827.
39. Steininger A, Mobs M, Ullmann R, Kochert K, Kreher S, Lamprecht B, Anagnostopoulos I, Hummel M, Richter J, Beyer M, et al. 2011. Genomic loss of the putative tumor suppressor gene E2A in human lymphoma. J Exp Med 208:1585-1593.
40. Tanaka Y, Kobayashi H, Suzuki M, Hirashima Y, Kanayama N, Terao T. 2004. Genetic downregulation of pregnancy-associated plasma protein-A (PAPP-A) by bikunin reduces IGF-I-dependent Akt and ERK1/2 activation and subsequently reduces ovarian cancer cell growth, invasion and metastasis. Int J Cancer 109:336-347.
41. Williams KC, Renthal NE, Gerard RD, Mendelson CR. 2012. The microRNA (miR)-199a/214 cluster mediates opposing effects of progesterone and estrogen on uterine contractility during pregnancy and labor. Mol Endocrinol 26:1857-1867.
42. Xia H, Ooi LL, Hui KM. 2012. MiR-214 Targets beta-Catenin Pathway to Suppress Invasion, Stem-Like Traits and Recurrence of Human Hepatocellular Carcinoma. PLoS One 7:e44206.
43. Xue W, Meylan E, Oliver TG, Feldser DM, Winslow MM, Bronson R, Jacks T. 2011. Response and resistance to NF-kappaB inhibitors in mouse models of lung adenocarcinoma. Cancer Discov 1:236-247.
44. Yuan Y, Cheng HZ, Li BL, Gong DJ, Zhuang CW, Wang SG, Zeng ZY, Huang SD. 2012. MicroRNA-98 and microRNA-214 post-transcriptionally regulate enhancer of zeste homolog 2 and inhibit migration and invasion in human esophageal squamous cell carcinoma. Mol Cancer 11:51.